A deep-learning approach to identify inhibitors of adherent-invasive Escherichia coli in the pathogenesis of inflammatory bowel disease

一种深度学习方法来识别炎症性肠病发病机制中粘附侵袭性大肠杆菌的抑制剂

• 批准号: 480198
• 负责人: Hu Pingzhao
• 金额: $ 60.47万
• 依托单位: University of Western Ontario
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2023
• 资助国家: 加拿大
• 起止时间: 2023-03-01 至 2028-03-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=480198&lang=en
• 关键词: Antibiotic Discovery; Data Integration; Deep Learning; Drug Design; Drug Repurposing; Escherichia Coli; Genetic Risk; Inflammatory Bowel Disease; Machine Learning; Pharmacological Properties

Inflammatory bowel disease (IBD) is a group of diseases causing the digestive system to have red, swollen, and sometimes painful inflammation in the long term. Canada is among the countries with the highest number of new diagnoses annually and the highest

炎症性肠病（IBD）是一组导致消化系统长期出现红肿，有时甚至疼痛的炎症的疾病。加拿大是每年新诊断人数最多的国家之一，也是最高的